Prestige Consumer Healthcare Inc. carries a market capitalization of 2.17B, placing it among publicly traded companies globally. Its enterprise value stands at 3.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.17B |
| Enterprise Value | 3.87B |
Prestige Consumer Healthcare Inc. currently has 47.32M shares outstanding.
| Shares Outstanding | 47.32M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Prestige Consumer Healthcare Inc. trades at a trailing price-to-earnings ratio of 15.20. The price-to-sales ratio is 2.66, and the price-to-book ratio stands at 1.66.
| PE Ratio | 15.20 |
| PS Ratio | 2.66 |
| PB Ratio | 1.66 |
| P/TBV Ratio | -2.91 |
| P/FCF Ratio | 10.82 |
| P/OCF Ratio | 11.23 |
On an enterprise value basis, Prestige Consumer Healthcare Inc. trades at an EV/EBITDA multiple of 11.37 and an EV/FCF ratio of 12.91. The EV/Sales ratio of 3.56 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.52 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.56 |
| EV / EBITDA | 11.37 |
| EV / EBIT | 12.52 |
| EV / FCF | 12.91 |
Prestige Consumer Healthcare Inc. maintains a current ratio of 3.57, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 55.39, indicating elevated leverage, while an interest coverage ratio of 8.05 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 3.57 |
| Quick Ratio | 2.12 |
| Debt / Equity | 55.39 |
| Debt / EBITDA | 3.07 |
| Interest Coverage | 8.05 |
Prestige Consumer Healthcare Inc. posts a return on equity of 11.52 and a return on invested capital of 7.87.
| Return on Equity (ROE) | 11.52 |
| Return on Assets (ROA) | 5.52 |
| Return on Invested Capital (ROIC) | 7.87 |
| Return on Capital Employed (ROCE) | 8.22 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.21 |
Over the trailing twelve months, Prestige Consumer Healthcare Inc. has paid 67.20M in income taxes, reflecting an effective tax rate of 26.10.
| Income Tax | 67.20M |
| Effective Tax Rate | 26.10 |
Prestige Consumer Healthcare Inc.'s stock has declined approximately -45.99976% over the past 52 weeks. The 50-day moving average sits at 54.25, while the 200-day moving average is 61.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | -45.99976% |
| 50-Day Moving Average | 54.25 |
| 200-Day Moving Average | 61.19 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Prestige Consumer Healthcare Inc. generated 1.09B in revenue and converted that into 190.30M in net income, yielding earnings per share of 3.88. EBITDA reached 340.68M, while operating income came in at 309.41M.
| Revenue | 1.09B |
| Gross Profit | 595.58M |
| Operating Income | 309.41M |
| Pretax Income | 257.50M |
| Net Income | 190.30M |
| EBITDA | 340.68M |
| EBIT | 309.41M |
| Earnings Per Share (EPS) | 3.88 |
Prestige Consumer Healthcare Inc. holds 63.87M in cash and equivalents against 1.05B in total debt, resulting in a net debt position of 933.07M. Total book value stands at 1.75B, with working capital of 310.56M providing operational flexibility.
| Cash & Cash Equivalents | 63.87M |
| Total Debt | 1.05B |
| Net Debt | 933.07M |
| Equity (Book Value) | 1.75B |
| Book Value Per Share | 35.80 |
| Working Capital | 310.56M |
Prestige Consumer Healthcare Inc. produced 257.63M in operating cash flow over the past twelve months. After subtracting -11.18M in capital expenditures, free cash flow totaled 246.45M - equivalent to 5.05 per share.
| Operating Cash Flow | 257.63M |
| Capital Expenditures | -11.18M |
| Free Cash Flow | 246.45M |
| FCF Per Share | 5.05 |
Prestige Consumer Healthcare Inc. operates with a gross margin of 54.71, reflecting its pricing power and cost economics. The operating margin of 28.42 and net profit margin of 17.48 provide insight into operational efficiency.
| Gross Margin | 54.71 |
| Operating Margin | 28.42 |
| Pretax Margin | 23.65 |
| Profit Margin | 17.48 |
| EBITDA Margin | 31.29 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 5.40 |
| FCF Yield | 9.24 |
Prestige Consumer Healthcare Inc. posts an Altman Z-Score of 9.11, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 9.11 |